A Study of Mirikizumab in Healthy Chinese Participants
Status:
Completed
Trial end date:
2020-12-11
Target enrollment:
Participant gender:
Summary
The main purpose of this study is to evaluate the safety of the study drug known as
mirikizumab. The study will investigate how the body processes the study drug. It will last
up to about 4 months for each participant.